Skip to content
Nanopharm-logo-with-signature-Pantone (1)
  • Home
  • About Us

    About Us

    Leadership Team

    Our Scientists
  • Services

    Product Development

    Preformulation & Preclinical

    Formulation & Drug Product Development

    Clinical Development

    Clinical Trial Manufacturing

    cGMP Release & Stability Testing

    Analytical Services

    Research & Development

    Spray Characterization

    Method Development
    cGMP Release & Stability

    IVBE & CMC Studies

    Alternative Bioequivalence

    In-Silico Modeling

    SmartTrack™

    PBPK Modeling

    Regional Deposition Modeling

    Regulatory

    Consultancy

    Alternative Bioequivalence
  • OINDP Expertise

    Nasal

    Nasal Powders

    Nasal Sprays

    Nasal Cast Deposition

    Inhalation

    DPI

    pMDI

    Low GWP Propellant pMDI

    Nebulizers

    Inhaled Biologics

    Generics & Lifecycle Management

    Reformulation & Repositioning

    IVBE

    Alternative Bioequivalence
  • Resources

    Resources

    Scientific Publications

    White Papers

    Posters
  • News & Events
  • Contact Us
  • Careers

Tag: OINDP

Optimising batch selection to increase success of PK studies for bioequivalence

Uncover Nanopharm’s SmartTrack approach for successful Pharmacokinetic and Bioequivalence studies in OINDP, using PBPK modelling.

Alternative Regulatory Pathway for Generic Inhaled Drugs

Uncover the pathways for generic OINDP and the challenges and solutions in the pharmaceutical regulatory landscape for inhalation drug products.

  CONTACT
+44 (0) 1633 372200
info@nanopharm.co.uk

Nanopharm Ltd
Franklin House, Grange Road, Cwmbran, NP44 3WY, United Kingdom   

STAY CONNECTED

Linkedin Youtube
General Terms and Conditions of Use and Privacy Policy
Terms & Conditions of Sales

© 2024. Nanopharm Ltd. All rights reserved.